We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
77 hedge funds and large institutions have $52.1M invested in Zevra Therapeutics in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
25% more capital invested
Capital invested by funds: $41.6M → $52.1M (+$10.5M)
8% more funds holding
Funds holding: 71 → 77 (+6)
7.76% more ownership
Funds ownership: 24.07% → 31.82% (+7.8%)
37% less call options, than puts
Call options by funds: $979K | Put options by funds: $1.54M
Holders
77
Holders Change
+6
Holders Change %
+8.45%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
25
Reduced
16
Closed
6
Calls
$979K
Puts
$1.54M
Net Calls
-$564K
Net Calls Change
-$1.34M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$263K |
| 2 |
DA
DSC Advisors
Chicago,
Illinois
|
-$250K |
| 3 |
Morgan Stanley
New York
|
-$118K |
| 4 |
VF
Virtu Financial
New York
|
-$112K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$63.4K |
